Aggregated specialty-pharmacy and hub patient-journey dataset

Aggregated specialty-pharmacy and hub patient-journey dataset: patient-level records stitched across more than 100 channel partners — specialty pharmacies, hubs, copay and free-drug programmes — spanning referral, therapy start, dispense, reimbursement (prior authorisation, affordability, denial), adherence and persistence, joined to claims, prescription, electronic health record, laboratory, formulary and policy, and provider and organisation reference data. The differentiated slice is the reimbursement-and-abandonment layer: why a prescribed specialty therapy fails to reach the patient, and at which step, which no claims-only source observes. Accessible through the SCRAII reporting layer and enriched by privacy-preserving linkage to external sources.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Data Unveil and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: PharmaceuticalsHealth Care Technology
Instruments: equities
Categories: Alternative

Dataset card

Type: not stated
Format: Multimodal structured data — tabular claims, prescription, dispensing and reimbursement records; formulary and policy documents; provider and organisation reference tables; longitudinal patient-journey event records joined across partners, delivered as a cloud platform with interactive reports, configurable views, alerts and downloadable extracts
Volume: More than 3 million specialty patients across 100+ brands and 100+ data partner feeds (vendor-stated breadth anchors). Inferred row volume: at tens to low hundreds of records per patient across claims, dispensing, referral, reimbursement and contact events, an estimated 500 million to 2 billion underlying rows, with the reimbursement and prior-authorisation layer the sparsest and most valuable component. The row count is an inference from the stated patient and brand counts, not a vendor figure.
Users: Client-side: an estimated 300-1,500 named user seats across an estimated 20-60 pharmaceutical manufacturer and partner client organisations, inferred from a ~122-employee firm operating a subscription platform across 100+ brands. Data subjects, not users, are the asset: more than 3 million patients tracked through specialty journeys (stated in the firm's own delivery-leadership profile).
History: 6 years
Update frequency: not stated
Growth: Active and rapidly expanding — company profile data reports roughly 122 employees with headcount up about 37 percent year over year (other trackers describe 100-150 employees with 50 percent growth), the firm has inaugurated additional Hyderabad facility space explicitly attributed to accelerated growth, and it is currently hiring US remote implementation and service-delivery leads. This is the fastest-growing vendor in this table.
Launched: 2020 — Data Unveil was founded in 2020, consistently reported across company-profile trackers, making it the youngest vendor in this table. Founder experience is described as 10+ years in the specialty-channel data domain at prior firms (Capgemini, LiquidHub), so the platform productised earlier practitioner capability rather than originating it; the SCRAII reporting layer was added later as the analytics front end and is still shipping updates.
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site